Global Paclitaxel-eluting Stent Market Insights and Forecast to 2026

Publisher Name :
Date: 04-Aug-2020
No. of pages: 110
Inquire Before Buying

Paclitaxel-eluting Stent market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Paclitaxel-eluting Stent market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Paclitaxel-eluting Stent market is segmented into

- Metal Stent

- Polymer Stent

- Others

Segment by Application, the Paclitaxel-eluting Stent market is segmented into

- Coronary Heart Disease

- Clinical

- Others

Regional and Country-level Analysis

The Paclitaxel-eluting Stent market is analysed and market size information is provided by regions (countries).

The key regions covered in the Paclitaxel-eluting Stent market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.

Competitive Landscape and Paclitaxel-eluting Stent Market Share Analysis

Paclitaxel-eluting Stent market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Paclitaxel-eluting Stent by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Paclitaxel-eluting Stent business, the date to enter into the Paclitaxel-eluting Stent market, Paclitaxel-eluting Stent product introduction, recent developments, etc.

The major vendors covered:

- B.Braun Melsengen AG

- Biosensors

- Biotronik

- Blue Medical

- Boston Scientific

- DISA Vascular

- Essen

- Medtronic Vascular

- MicroPort Medical

- Terumo Medical

- Orbusneich

Global Paclitaxel-eluting Stent Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Paclitaxel-eluting Stent Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Paclitaxel-eluting Stent Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Paclitaxel-eluting Stent Market Size Growth Rate by Type
1.4.2 Metal Stent
1.4.3 Polymer Stent
1.4.4 Others
1.5 Market by Application
1.5.1 Global Paclitaxel-eluting Stent Market Size Growth Rate by Application
1.5.2 Coronary Heart Disease
1.5.3 Clinical
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Paclitaxel-eluting Stent Market Size, Estimates and Forecasts
2.1.1 Global Paclitaxel-eluting Stent Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Paclitaxel-eluting Stent Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Paclitaxel-eluting Stent Production Estimates and Forecasts 2015-2026
2.2 Global Paclitaxel-eluting Stent, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Paclitaxel-eluting Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Paclitaxel-eluting Stent Manufacturers Geographical Distribution
2.4 Key Trends for Paclitaxel-eluting Stent Markets & Products
2.5 Primary Interviews with Key Paclitaxel-eluting Stent Players (Opinion Leaders)
3 Market Size by Manufacturers
3.1 Global Top Paclitaxel-eluting Stent Manufacturers by Production Capacity
3.1.1 Global Top Paclitaxel-eluting Stent Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Paclitaxel-eluting Stent Manufacturers by Production (2015-2020)
3.1.3 Global Top Paclitaxel-eluting Stent Manufacturers Market Share by Production
3.2 Global Top Paclitaxel-eluting Stent Manufacturers by Revenue
3.2.1 Global Top Paclitaxel-eluting Stent Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Paclitaxel-eluting Stent Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Paclitaxel-eluting Stent Revenue in 2019
3.3 Global Paclitaxel-eluting Stent Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 Paclitaxel-eluting Stent Production by Regions
4.1 Global Paclitaxel-eluting Stent Historic Market Facts & Figures by Regions
4.1.1 Global Top Paclitaxel-eluting Stent Regions by Production (2015-2020)
4.1.2 Global Top Paclitaxel-eluting Stent Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Paclitaxel-eluting Stent Production (2015-2020)
4.2.2 North America Paclitaxel-eluting Stent Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Paclitaxel-eluting Stent Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Paclitaxel-eluting Stent Production (2015-2020)
4.3.2 Europe Paclitaxel-eluting Stent Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Paclitaxel-eluting Stent Import & Export (2015-2020)
4.4 China
4.4.1 China Paclitaxel-eluting Stent Production (2015-2020)
4.4.2 China Paclitaxel-eluting Stent Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Paclitaxel-eluting Stent Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Paclitaxel-eluting Stent Production (2015-2020)
4.5.2 Japan Paclitaxel-eluting Stent Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Paclitaxel-eluting Stent Import & Export (2015-2020)
5 Paclitaxel-eluting Stent Consumption by Region
5.1 Global Top Paclitaxel-eluting Stent Regions by Consumption
5.1.1 Global Top Paclitaxel-eluting Stent Regions by Consumption (2015-2020)
5.1.2 Global Top Paclitaxel-eluting Stent Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Paclitaxel-eluting Stent Consumption by Application
5.2.2 North America Paclitaxel-eluting Stent Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Paclitaxel-eluting Stent Consumption by Application
5.3.2 Europe Paclitaxel-eluting Stent Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Paclitaxel-eluting Stent Consumption by Application
5.4.2 Asia Pacific Paclitaxel-eluting Stent Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Paclitaxel-eluting Stent Consumption by Application
5.5.2 Central & South America Paclitaxel-eluting Stent Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Paclitaxel-eluting Stent Consumption by Application
5.6.2 Middle East and Africa Paclitaxel-eluting Stent Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 Market Size by Type (2015-2026)
6.1 Global Paclitaxel-eluting Stent Market Size by Type (2015-2020)
6.1.1 Global Paclitaxel-eluting Stent Production by Type (2015-2020)
6.1.2 Global Paclitaxel-eluting Stent Revenue by Type (2015-2020)
6.1.3 Paclitaxel-eluting Stent Price by Type (2015-2020)
6.2 Global Paclitaxel-eluting Stent Market Forecast by Type (2021-2026)
6.2.1 Global Paclitaxel-eluting Stent Production Forecast by Type (2021-2026)
6.2.2 Global Paclitaxel-eluting Stent Revenue Forecast by Type (2021-2026)
6.2.3 Global Paclitaxel-eluting Stent Price Forecast by Type (2021-2026)
6.3 Global Paclitaxel-eluting Stent Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 Market Size by Application (2015-2026)
7.2.1 Global Paclitaxel-eluting Stent Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Paclitaxel-eluting Stent Consumption Forecast by Application (2021-2026)
8 Corporate Profiles
8.1 B.Braun Melsengen AG
8.1.1 B.Braun Melsengen AG Corporation Information
8.1.2 B.Braun Melsengen AG Overview
8.1.3 B.Braun Melsengen AG Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 B.Braun Melsengen AG Product Description
8.1.5 B.Braun Melsengen AG Related Developments
8.2 Biosensors
8.2.1 Biosensors Corporation Information
8.2.2 Biosensors Overview
8.2.3 Biosensors Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Biosensors Product Description
8.2.5 Biosensors Related Developments
8.3 Biotronik
8.3.1 Biotronik Corporation Information
8.3.2 Biotronik Overview
8.3.3 Biotronik Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Biotronik Product Description
8.3.5 Biotronik Related Developments
8.4 Blue Medical
8.4.1 Blue Medical Corporation Information
8.4.2 Blue Medical Overview
8.4.3 Blue Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Blue Medical Product Description
8.4.5 Blue Medical Related Developments
8.5 Boston Scientific
8.5.1 Boston Scientific Corporation Information
8.5.2 Boston Scientific Overview
8.5.3 Boston Scientific Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Boston Scientific Product Description
8.5.5 Boston Scientific Related Developments
8.6 DISA Vascular
8.6.1 DISA Vascular Corporation Information
8.6.2 DISA Vascular Overview
8.6.3 DISA Vascular Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 DISA Vascular Product Description
8.6.5 DISA Vascular Related Developments
8.7 Essen
8.7.1 Essen Corporation Information
8.7.2 Essen Overview
8.7.3 Essen Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Essen Product Description
8.7.5 Essen Related Developments
8.8 Medtronic Vascular
8.8.1 Medtronic Vascular Corporation Information
8.8.2 Medtronic Vascular Overview
8.8.3 Medtronic Vascular Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Medtronic Vascular Product Description
8.8.5 Medtronic Vascular Related Developments
8.9 MicroPort Medical
8.9.1 MicroPort Medical Corporation Information
8.9.2 MicroPort Medical Overview
8.9.3 MicroPort Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 MicroPort Medical Product Description
8.9.5 MicroPort Medical Related Developments
8.10 Terumo Medical
8.10.1 Terumo Medical Corporation Information
8.10.2 Terumo Medical Overview
8.10.3 Terumo Medical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Terumo Medical Product Description
8.10.5 Terumo Medical Related Developments
8.11 Orbusneich
8.11.1 Orbusneich Corporation Information
8.11.2 Orbusneich Overview
8.11.3 Orbusneich Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 Orbusneich Product Description
8.11.5 Orbusneich Related Developments
9 Paclitaxel-eluting Stent Production Forecast by Regions
9.1 Global Top Paclitaxel-eluting Stent Regions Forecast by Revenue (2021-2026)
9.2 Global Top Paclitaxel-eluting Stent Regions Forecast by Production (2021-2026)
9.3 Key Paclitaxel-eluting Stent Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 Paclitaxel-eluting Stent Consumption Forecast by Region
10.1 Global Paclitaxel-eluting Stent Consumption Forecast by Region (2021-2026)
10.2 North America Paclitaxel-eluting Stent Consumption Forecast by Region (2021-2026)
10.3 Europe Paclitaxel-eluting Stent Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Paclitaxel-eluting Stent Consumption Forecast by Region (2021-2026)
10.5 Latin America Paclitaxel-eluting Stent Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Paclitaxel-eluting Stent Consumption Forecast by Region (2021-2026)
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Paclitaxel-eluting Stent Sales Channels
11.2.2 Paclitaxel-eluting Stent Distributors
11.3 Paclitaxel-eluting Stent Customers
12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
12.1 Paclitaxel-eluting Stent Industry
12.2 Market Trends
12.3 Market Opportunities and Drivers
12.4 Market Challenges
12.5 Paclitaxel-eluting Stent Market Risks/Restraints
12.6 Porter's Five Forces Analysis
13 Key Finding in The Global Paclitaxel-eluting Stent Study
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Paclitaxel-eluting Stent Key Market Segments in This Study
Table 2. Ranking of Global Top Paclitaxel-eluting Stent Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Paclitaxel-eluting Stent Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of Metal Stent
Table 5. Major Manufacturers of Polymer Stent
Table 6. Major Manufacturers of Others
Table 7. Global Paclitaxel-eluting Stent Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Paclitaxel-eluting Stent Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 9. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 10. Global Paclitaxel-eluting Stent by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paclitaxel-eluting Stent as of 2019)
Table 11. Paclitaxel-eluting Stent Manufacturing Base Distribution and Headquarters
Table 12. Manufacturers Paclitaxel-eluting Stent Product Offered
Table 13. Date of Manufacturers Enter into Paclitaxel-eluting Stent Market
Table 14. Key Trends for Paclitaxel-eluting Stent Markets & Products
Table 15. Main Points Interviewed from Key Paclitaxel-eluting Stent Players
Table 16. Global Paclitaxel-eluting Stent Production Capacity by Manufacturers (2015-2020) (K Units)
Table 17. Global Paclitaxel-eluting Stent Production Share by Manufacturers (2015-2020)
Table 18. Paclitaxel-eluting Stent Revenue by Manufacturers (2015-2020) (Million US$)
Table 19. Paclitaxel-eluting Stent Revenue Share by Manufacturers (2015-2020)
Table 20. Paclitaxel-eluting Stent Price by Manufacturers 2015-2020 (USD/Unit)
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Paclitaxel-eluting Stent Production by Regions (2015-2020) (K Units)
Table 23. Global Paclitaxel-eluting Stent Production Market Share by Regions (2015-2020)
Table 24. Global Paclitaxel-eluting Stent Revenue by Regions (2015-2020) (US$ Million)
Table 25. Global Paclitaxel-eluting Stent Revenue Market Share by Regions (2015-2020)
Table 26. Key Paclitaxel-eluting Stent Players in North America
Table 27. Import & Export of Paclitaxel-eluting Stent in North America (K Units)
Table 28. Key Paclitaxel-eluting Stent Players in Europe
Table 29. Import & Export of Paclitaxel-eluting Stent in Europe (K Units)
Table 30. Key Paclitaxel-eluting Stent Players in China
Table 31. Import & Export of Paclitaxel-eluting Stent in China (K Units)
Table 32. Key Paclitaxel-eluting Stent Players in Japan
Table 33. Import & Export of Paclitaxel-eluting Stent in Japan (K Units)
Table 34. Global Paclitaxel-eluting Stent Consumption by Regions (2015-2020) (K Units)
Table 35. Global Paclitaxel-eluting Stent Consumption Market Share by Regions (2015-2020)
Table 36. North America Paclitaxel-eluting Stent Consumption by Application (2015-2020) (K Units)
Table 37. North America Paclitaxel-eluting Stent Consumption by Countries (2015-2020) (K Units)
Table 38. Europe Paclitaxel-eluting Stent Consumption by Application (2015-2020) (K Units)
Table 39. Europe Paclitaxel-eluting Stent Consumption by Countries (2015-2020) (K Units)
Table 40. Asia Pacific Paclitaxel-eluting Stent Consumption by Application (2015-2020) (K Units)
Table 41. Asia Pacific Paclitaxel-eluting Stent Consumption Market Share by Application (2015-2020) (K Units)
Table 42. Asia Pacific Paclitaxel-eluting Stent Consumption by Regions (2015-2020) (K Units)
Table 43. Latin America Paclitaxel-eluting Stent Consumption by Application (2015-2020) (K Units)
Table 44. Latin America Paclitaxel-eluting Stent Consumption by Countries (2015-2020) (K Units)
Table 45. Middle East and Africa Paclitaxel-eluting Stent Consumption by Application (2015-2020) (K Units)
Table 46. Middle East and Africa Paclitaxel-eluting Stent Consumption by Countries (2015-2020) (K Units)
Table 47. Global Paclitaxel-eluting Stent Production by Type (2015-2020) (K Units)
Table 48. Global Paclitaxel-eluting Stent Production Share by Type (2015-2020)
Table 49. Global Paclitaxel-eluting Stent Revenue by Type (2015-2020) (Million US$)
Table 50. Global Paclitaxel-eluting Stent Revenue Share by Type (2015-2020)
Table 51. Paclitaxel-eluting Stent Price by Type 2015-2020 (USD/Unit)
Table 52. Global Paclitaxel-eluting Stent Consumption by Application (2015-2020) (K Units)
Table 53. Global Paclitaxel-eluting Stent Consumption Share by Application (2015-2020)
Table 54. B.Braun Melsengen AG Corporation Information
Table 55. B.Braun Melsengen AG Description and Major Businesses
Table 56. B.Braun Melsengen AG Paclitaxel-eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 57. B.Braun Melsengen AG Product
Table 58. B.Braun Melsengen AG Recent Development
Table 59. Biosensors Corporation Information
Table 60. Biosensors Description and Major Businesses
Table 61. Biosensors Paclitaxel-eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 62. Biosensors Product
Table 63. Biosensors Recent Development
Table 64. Biotronik Corporation Information
Table 65. Biotronik Description and Major Businesses
Table 66. Biotronik Paclitaxel-eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 67. Biotronik Product
Table 68. Biotronik Recent Development
Table 69. Blue Medical Corporation Information
Table 70. Blue Medical Description and Major Businesses
Table 71. Blue Medical Paclitaxel-eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Blue Medical Product
Table 73. Blue Medical Recent Development
Table 74. Boston Scientific Corporation Information
Table 75. Boston Scientific Description and Major Businesses
Table 76. Boston Scientific Paclitaxel-eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Boston Scientific Product
Table 78. Boston Scientific Recent Development
Table 79. DISA Vascular Corporation Information
Table 80. DISA Vascular Description and Major Businesses
Table 81. DISA Vascular Paclitaxel-eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. DISA Vascular Product
Table 83. DISA Vascular Recent Development
Table 84. Essen Corporation Information
Table 85. Essen Description and Major Businesses
Table 86. Essen Paclitaxel-eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Essen Product
Table 88. Essen Recent Development
Table 89. Medtronic Vascular Corporation Information
Table 90. Medtronic Vascular Description and Major Businesses
Table 91. Medtronic Vascular Paclitaxel-eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Medtronic Vascular Product
Table 93. Medtronic Vascular Recent Development
Table 94. MicroPort Medical Corporation Information
Table 95. MicroPort Medical Description and Major Businesses
Table 96. MicroPort Medical Paclitaxel-eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. MicroPort Medical Product
Table 98. MicroPort Medical Recent Development
Table 99. Terumo Medical Corporation Information
Table 100. Terumo Medical Description and Major Businesses
Table 101. Terumo Medical Paclitaxel-eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Terumo Medical Product
Table 103. Terumo Medical Recent Development
Table 104. Orbusneich Corporation Information
Table 105. Orbusneich Description and Major Businesses
Table 106. Orbusneich Paclitaxel-eluting Stent Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Orbusneich Product
Table 108. Orbusneich Recent Development
Table 109. Global Paclitaxel-eluting Stent Revenue Forecast by Region (2021-2026) (Million US$)
Table 110. Global Paclitaxel-eluting Stent Production Forecast by Regions (2021-2026) (K Units)
Table 111. Global Paclitaxel-eluting Stent Production Forecast by Type (2021-2026) (K Units)
Table 112. Global Paclitaxel-eluting Stent Revenue Forecast by Type (2021-2026) (Million US$)
Table 113. North America Paclitaxel-eluting Stent Consumption Forecast by Regions (2021-2026) (K Units)
Table 114. Europe Paclitaxel-eluting Stent Consumption Forecast by Regions (2021-2026) (K Units)
Table 115. Asia Pacific Paclitaxel-eluting Stent Consumption Forecast by Regions (2021-2026) (K Units)
Table 116. Latin America Paclitaxel-eluting Stent Consumption Forecast by Regions (2021-2026) (K Units)
Table 117. Middle East and Africa Paclitaxel-eluting Stent Consumption Forecast by Regions (2021-2026) (K Units)
Table 118. Paclitaxel-eluting Stent Distributors List
Table 119. Paclitaxel-eluting Stent Customers List
Table 120. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 121. Key Challenges
Table 122. Market Risks
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Paclitaxel-eluting Stent Product Picture
Figure 2. Global Paclitaxel-eluting Stent Production Market Share by Type in 2020 & 2026
Figure 3. Metal Stent Product Picture
Figure 4. Polymer Stent Product Picture
Figure 5. Others Product Picture
Figure 6. Global Paclitaxel-eluting Stent Consumption Market Share by Application in 2020 & 2026
Figure 7. Coronary Heart Disease
Figure 8. Clinical
Figure 9. Others
Figure 10. Paclitaxel-eluting Stent Report Years Considered
Figure 11. Global Paclitaxel-eluting Stent Revenue 2015-2026 (Million US$)
Figure 12. Global Paclitaxel-eluting Stent Production Capacity 2015-2026 (K Units)
Figure 13. Global Paclitaxel-eluting Stent Production 2015-2026 (K Units)
Figure 14. Global Paclitaxel-eluting Stent Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 15. Paclitaxel-eluting Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Paclitaxel-eluting Stent Production Share by Manufacturers in 2015
Figure 17. The Top 10 and Top 5 Players Market Share by Paclitaxel-eluting Stent Revenue in 2019
Figure 18. Global Paclitaxel-eluting Stent Production Market Share by Region (2015-2020)
Figure 19. Paclitaxel-eluting Stent Production Growth Rate in North America (2015-2020) (K Units)
Figure 20. Paclitaxel-eluting Stent Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 21. Paclitaxel-eluting Stent Production Growth Rate in Europe (2015-2020) (K Units)
Figure 22. Paclitaxel-eluting Stent Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 23. Paclitaxel-eluting Stent Production Growth Rate in China (2015-2020) (K Units)
Figure 24. Paclitaxel-eluting Stent Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 25. Paclitaxel-eluting Stent Production Growth Rate in Japan (2015-2020) (K Units)
Figure 26. Paclitaxel-eluting Stent Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 27. Global Paclitaxel-eluting Stent Consumption Market Share by Regions 2015-2020
Figure 28. North America Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 29. North America Paclitaxel-eluting Stent Consumption Market Share by Application in 2019
Figure 30. North America Paclitaxel-eluting Stent Consumption Market Share by Countries in 2019
Figure 31. U.S. Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 32. Canada Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 33. Europe Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 34. Europe Paclitaxel-eluting Stent Consumption Market Share by Application in 2019
Figure 35. Europe Paclitaxel-eluting Stent Consumption Market Share by Countries in 2019
Figure 36. Germany Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 37. France Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 38. U.K. Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 39. Italy Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 40. Russia Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 41. Asia Pacific Paclitaxel-eluting Stent Consumption and Growth Rate (K Units)
Figure 42. Asia Pacific Paclitaxel-eluting Stent Consumption Market Share by Application in 2019
Figure 43. Asia Pacific Paclitaxel-eluting Stent Consumption Market Share by Regions in 2019
Figure 44. China Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 45. Japan Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 46. South Korea Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 47. India Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 48. Australia Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. Taiwan Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. Indonesia Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. Thailand Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Malaysia Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Philippines Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 54. Vietnam Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 55. Latin America Paclitaxel-eluting Stent Consumption and Growth Rate (K Units)
Figure 56. Latin America Paclitaxel-eluting Stent Consumption Market Share by Application in 2019
Figure 57. Latin America Paclitaxel-eluting Stent Consumption Market Share by Countries in 2019
Figure 58. Mexico Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 59. Brazil Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 60. Argentina Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 61. Middle East and Africa Paclitaxel-eluting Stent Consumption and Growth Rate (K Units)
Figure 62. Middle East and Africa Paclitaxel-eluting Stent Consumption Market Share by Application in 2019
Figure 63. Middle East and Africa Paclitaxel-eluting Stent Consumption Market Share by Countries in 2019
Figure 64. Turkey Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 65. Saudi Arabia Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 66. U.A.E Paclitaxel-eluting Stent Consumption and Growth Rate (2015-2020) (K Units)
Figure 67. Global Paclitaxel-eluting Stent Production Market Share by Type (2015-2020)
Figure 68. Global Paclitaxel-eluting Stent Production Market Share by Type in 2019
Figure 69. Global Paclitaxel-eluting Stent Revenue Market Share by Type (2015-2020)
Figure 70. Global Paclitaxel-eluting Stent Revenue Market Share by Type in 2019
Figure 71. Global Paclitaxel-eluting Stent Production Market Share Forecast by Type (2021-2026)
Figure 72. Global Paclitaxel-eluting Stent Revenue Market Share Forecast by Type (2021-2026)
Figure 73. Global Paclitaxel-eluting Stent Market Share by Price Range (2015-2020)
Figure 74. Global Paclitaxel-eluting Stent Consumption Market Share by Application (2015-2020)
Figure 75. Global Paclitaxel-eluting Stent Value (Consumption) Market Share by Application (2015-2020)
Figure 76. Global Paclitaxel-eluting Stent Consumption Market Share Forecast by Application (2021-2026)
Figure 77. Global Paclitaxel-eluting Stent Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 78. Global Paclitaxel-eluting Stent Revenue Market Share Forecast by Regions ((2021-2026))
Figure 79. Global Paclitaxel-eluting Stent Production Forecast by Regions (2021-2026) (K Units)
Figure 80. North America Paclitaxel-eluting Stent Production Forecast (2021-2026) (K Units)
Figure 81. North America Paclitaxel-eluting Stent Revenue Forecast (2021-2026) (US$ Million)
Figure 82. Europe Paclitaxel-eluting Stent Production Forecast (2021-2026) (K Units)
Figure 83. Europe Paclitaxel-eluting Stent Revenue Forecast (2021-2026) (US$ Million)
Figure 84. China Paclitaxel-eluting Stent Production Forecast (2021-2026) (K Units)
Figure 85. China Paclitaxel-eluting Stent Revenue Forecast (2021-2026) (US$ Million)
Figure 86. Japan Paclitaxel-eluting Stent Production Forecast (2021-2026) (K Units)
Figure 87. Japan Paclitaxel-eluting Stent Revenue Forecast (2021-2026) (US$ Million)
Figure 88. Global Paclitaxel-eluting Stent Consumption Market Share Forecast by Region (2021-2026)
Figure 89. Paclitaxel-eluting Stent Value Chain
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Porter's Five Forces Analysis
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs